The recordings of EPA 2020’s programme are available in the virtual platform.
Please use the login page to access the virtual congress platform and all the sessions available on-demand, exhibition and industry sessions, e-Poster presentations and list of participants per country.
The European Congress of Psychiatry serves the educational mission of the EPA by providing high-quality EPA Courses, covering all aspects of psychiatry. Fees are charged separately for the courses. Each EPA Course is composed of two 90-minute sessions.
The State-of-the-Art lectures have a strong clinical focus, providing a complete update on significant aspects of current clinical treatments in European psychiatry. The State-of-the-Art lectures are delivered by top European or worldwide experts and last 45 minutes.
The Plenary lectures are mainly theoretical and research-oriented, with a strong scientific focus. These lectures are delivered by leading psychiatrists, scientists and other mental health professionals invited by the Scientific Programme Committee. They cover the major topics of the Congress theme.
Debates offer a lively and fruitful discussion on controversial issues. A chairperson moderates the debate and the following discussion, while two speakers (proponent /opponent) offer and challenge opinions on “hot topics” for 30 minutes each. Participants may also be asked to interact by voting at the beginning and/or end of the session.
These 90-minute sessions, selected by the Scientific Programme Committee, focus on specific topics in psychiatry, representing several points of view. Each symposium includes four presentations by international speakers and offers an opportunity for discussion at the end.
The Workshops are devoted to a specific topic and bring together experts in this field for an intensive discussion. These are 90-minute working sessions, with 30 minutes devoted to discussion and interactivity.
The EPA invites recent graduates to follow its specialist programme, which is tailored to the needs and interests of early career psychiatrists. The ECP Programme is composed of a Networking Evening and a special track of sessions throughout the Congress.
Ask the Experts sessions allow participants to meet in a small group with outstanding researchers and clinicians. The format is designed to facilitate informal discussions, allowing participants to present their questions and gain new perspectives. Sessions take place at round tables and are limited to a certain number of participants with advanced sign-up required.
The EPA Forums brings together EPA Council of National Psychiatric Association (NPA) members and individual EPA members, along with other European organisations, stakeholders and policy makers, to present and discuss matters of European importance in the field of Mental Health and Mental Health Care.
Authors are invited to submit abstracts, classified by topics. There is a limitation concerning the number of submissions per individual. Submitted abstracts are reviewed by the Scientific Programme Committee and scheduled as Oral Communications Sessions, e-Poster Presentations, or e-Poster Viewing.
Those abstracts scoring the highest will be allotted an Oral Communication Session in which the author will have 8-10 minutes to present the research in the presence of colleagues with related research.
Authors in the second-highest category of scoring are invited to present their research findings or important ongoing research as an e-Poster Presentation, where they have 3 minutes to present their e-Posters with an audio recording.
All other authors accepted for e-Poster status will be able to view their poster in the virtual platform. The e-posters are accessible to all delegates throughout the Congress for individual viewing. All accepted posters whose authors attended the Congress are published in the European Psychiatry Digital Abstract Supplement during and following the Congress.
Satellite Symposia are organised by pharmaceutical companies in consultation with the Scientific Programme Committee. These sessions are fully integrated into the Congress, but are sessions entirely designed, produced and driven by the pharmaceutical industries by an unrestricted educational grant.